The company will ask federal regulators to increase the amount of coronavirus vaccine it can put in each vial by as much as 50 percent, potentially bolstering availability quickly.The company will ask federal regulators to increase the amount of coronavirus vaccine it can put in each vial by as much as 50 percent, potentially bolstering availability quickly.Coronavirus (2019-nCoV), Moderna Inc, Vaccination and Immunization, Drugs (Pharmaceuticals), Shortages, Factories and Manufacturing, Regulation and Deregulation of Industry, Food and Drug Administration, United States Politics and Government, Biden, Joseph R JrRead More
